T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome

Clinical Cancer Research

Volumn 14, Issue 3, 2008, Pages 692-700

  Baleydier, Frederic ^a   Decouvelaere, Anne Valerie ^f   Bergeron, Julie ^a   Gaulard, Philippe ^c   Canioni, Danielle ^b   Bertrand, Yves ^g   Lepretre, Stephane ^h   Petit, Barbara ⁱ   Dombret, Herve ^d   Beldjord, Kheira ^a,b   Molina, Thierry ^e   Asnafi, Vahid ^a,b   Macintyre, Elizabeth ^a,b  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HÔTEL DIEU   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g HÔPITAL DEBROUSSE   (France)

^h CENTRE HENRI BECQUEREL   (France)

ⁱ UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE; GENE EXPRESSION; GENE REARRANGEMENT; GENOTYPE; HOXA GENE; HUMAN; HUMAN CELL; IMMUNOGENETICS; IMMUNOHISTOCHEMISTRY; LYMPHOBLASTOMA; MALE; MEDIASTINUM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOBLASTIC LYMPHOMA; TLX1 GENE;

ADOLESCENT; ADULT; AGED; BIOPSY; CHILD; CHILD, PRESCHOOL; DNA, NEOPLASM; FEMALE; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; PLEURAL EFFUSION; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; RECEPTORS, ANTIGEN, T-CELL; RETROSPECTIVE STUDIES;

EID: 38949188663     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1927     Document Type: Article

References (45)

1. Uppenkamp M, Feller AC. Classification of malignant lymphoma. Onkologie 2002;25:563-70.
2. Hoelzer D, Gokbuget N, Digel W, et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002;99:4379-85.
3. Brousse N, Vasiliu V, Michon J, Canioni D. Pediatric non-Hodgkin lymphomas. Ann Pathol 2004;24:574-86.
4. Reiter A, Schrappe M, Ludwig WD, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 2000;95:416-21.
5. Asnafi V, Beldjord K, Boulanger E, et al. Analysis of TCR, pTα, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 2003;101:2693-703.
6. Spits H. Development of αβ T cells in the human thymus. Nat Rev Immunol 2002;2:760-72.
7. Blom B, Verschuren MC, Heemskerk MH, et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood 1999;93:3033-43.
8. Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoeven MA, van Wering ER, van Dongen JJ. Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-δ gene rearrangements in acute lymphoblastic leukemia. Blood 1993;82:3063-74.
9. Hayday AC. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000;18:975-1026.
10. Dudley EC, Girardi M, Owen MJ, Hayday AC. Alpha beta and gamma delta T cells can share a late common precursor. Curr Biol 1995;5:659-69.
11. Langerak AW, Wolvers-Tettero IL, van den Beemd MW, et al. Immunophenotypic and immunogenotypic characteristics of TCRγδ+ T cell acute lymphoblastic leukemia. Leukemia 1999;13:206-14.
12. Asnafi V, Radford-Weiss I, Dastugue N, et al. CALM-AF10 isa common fusion transcript in T-ALL and is specific to the TCRγδ lineage. Blood 2003;102:1000-6.
13. Ferrando AA, Armstrong SA, Neuberg DS, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 2003;102:262-8.
14. Asnafi V, Beldjord K, Libura M, et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004;104:4173-80.
15. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002;1:75-87.
16. Soulier J, Clappier E, Cayuela JM, et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005;106:274-86.
17. Speleman F, Cauwelier B, Dastugue N, et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia 2005;19:358-66.
18. Bergeron J, Clappier E, Cauwelier B, et al. HOXA cluster deregulation in T-ALL associated with both a TCRD-HOXA and a CALM-AF10 chromosomal translocation. Leukemia 2006;20:1184-7.
19. Armstrong SA, Staunton JE, Silverman LB, et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002;30:41-7.
20. Dik WA, Brahim W, Braun C, et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 2005;19:1948-57.
21. Le Gouill S, Lepretre S, Briere J, et al. Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemia 2003;17:2220-4.
22. Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003;21:774-80.
23. Jabbour E, Koscielny S, Sebban C, et al. High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL). Leukemia 2006;20:814-9.
24. Bergeron C, Peral D, Paquamput H, et al. Treatment of childhood T cell lymphoblastic lymphoma (TLL), results of the SFOP LMT96. Blood 2005;106:929a.
25. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
26. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocolsf or detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4 - 98 - 3936. Leukemia 2003;17:2257-317.
27. Macintyre EA, Smit L, Ritz J, Kirsch IR, Strominger JL. Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor αβ lineage. Blood 1992;80:1511-20.
28. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003;17:2318-57.
29. Delabesse E, Bernard M, Landman-Parker J, et al. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants. Br J Haematol 1997;99:901-7.
30. Graux C, Cools J, Melotte C, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004;36:1084-9.
31. Burkhardt B, Bruch J, Zimmermann M, et al. Loss of heterozygosity on chromosome 6q14-24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia 2006;20:1422-9.
32. Lin CW, Liu TY, Chen SU, Wang KT, Medeiros LJ, Hsu SM. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features. Blood 2005;106:3567-74.
33. Ferrando AA, Neuberg DS, Dodge RK, et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet 2004;363:535-6.
34. Cave H, Suciu S, Preudhomme C, et al. Clinical significance of HOX11L2 expression linked to t(5;14) (q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004;103:442-50.
35. Asnafi V, Buzyn A, Thomas X, et al. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. Blood 2005;105:3072-8.
36. Wuchter C, Ruppert V, Schrappe M, Dorken B, Ludwig WD, Karawajew L. In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia. Blood 2002;99:4109-15.
37. Taghon T, Thys K, De Smedt M, et al. Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development. Leukemia 2003;17:1157-63.
38. Dik WA, Pike-Overzet K, Weerkamp F, et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 2005;201:1715-23.
39. Ellison DA, Parham DM, Sawyer JR. Cytogenetic findings in pediatric T-lymphoblastic lymphomas: one institution's experience and a review of the literature. Pediatr Dev Pathol 2005;8:550-6.
40. Burmeister T, Gokbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S. NUP214-1 in adult T-ALL: the GMALL study group experience. Blood 2006;108:3556-9.
41. Escribano L, Ocqueteau M, Almeida J, Orfao A, San Miguel JF. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma 1998;30:459-66.
42. Freud AG, Becknell B, Roychowdhury S, et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005;22:295-304.
43. Murre C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 2005;6:1079-86.
44. Lin YW, Aplan PD. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets. Leukemia 2007;21:1276-84.
45. Raetz EA, Perkins SL, Bhojwani D, et al. Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Pediatr Blood Cancer 2006;47:130-40.